Literature DB >> 8401928

Halothane inhibits the pressor effect of diphenyleneiodonium.

Y X Wang1, C C Pang.   

Abstract

1. We have recently found that diphenyleneiodonium (DPI), a novel inhibitor of nitric oxide (NO) synthase, causes pressor and tachycardic responses in pentobarbitone- but not halothane-anaesthetized rats. The present study investigated the mechanism by which halothane suppresses the pressor response of DPI. The effects of halothane on the pressor response of DPI were also compared with those of other anaesthetic agents. 2. In conscious rats, i.v. bolus injections of DPI (0.025- 1.6 mg kg-1) caused dose-dependent increases in mean arterial pressure (MAP), with ED90 of 0.07 +/- 0.01 mg kg-1 and maximal rise of MAP (Emax) of 59 +/- 2 mmHg. While ketamine potentiated Emax without altering the ED50 and pentobarbitone increased the ED50 without changing Emax of the pressor response to DPI, chloralose, urethane and ethanol displaced the curve to the right and potentiated Emax. In contrast, halothane (0.5-1.25%) dose-dependently and non-competitively reduced the pressor responses to DPI. 3. Intravenous bolus injection of a single dose of DPI (1.6 mg kg-1) caused immediate and large increases in plasma noradrenaline and adrenaline, as well as MAP in conscious rats. Halothane (1.25%) almost completely inhibited these increases. 4. The results suggest that DPI causes a pressor response in conscious rats by activating the sympathetic nervous system and halothane abolishes this pressor response by inhibiting activities of the sympathetic nervous system. The results also show that influences of anaesthetics must be taken into consideration when evaluating pressor response of vasoactive agents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401928      PMCID: PMC2175759          DOI: 10.1111/j.1476-5381.1993.tb13747.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Transmitter release at mouse motor nerve terminals mediated by temporary accumulation of intracellular barium.

Authors:  D M Quastel; D A Saint
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

2.  Halothane decreases the release of neuropeptide Y and 3,4-dihydroxyphenylglycol from superfused segments of dog pulmonary artery.

Authors:  D K Rorie; L W Hunter; J J Lunn
Journal:  Anesthesiology       Date:  1990-10       Impact factor: 7.892

3.  The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages.

Authors:  J T Hancock; O T Jones
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

4.  FAD and GSH participate in macrophage synthesis of nitric oxide.

Authors:  D J Stuehr; N S Kwon; C F Nathan
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

5.  Studies on the electron-transfer mechanism of the human neutrophil NADPH oxidase.

Authors:  J A Ellis; A R Cross; O T Jones
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

6.  The effects of halothane on sympathetic ganglionic transmission.

Authors:  Z J Bosnjak; J L Seagard; A Wu; J P Kampine
Journal:  Anesthesiology       Date:  1982-12       Impact factor: 7.892

7.  Halothane selectively attenuates alpha 2-adrenoceptor mediated vasoconstriction, in vivo and in vitro.

Authors:  D R Larach; H G Schuler; J A Derr; M G Larach; F A Hensley; R Zelis
Journal:  Anesthesiology       Date:  1987-06       Impact factor: 7.892

8.  Halothane-induced changes in the release and disposition of norepinephrine at adrenergic nerve endings in dog saphenous vein.

Authors:  J J Lunn; D K Rorie
Journal:  Anesthesiology       Date:  1984-10       Impact factor: 7.892

9.  Clinical concentrations of volatile anesthetics reduce depolarization-evoked release of [3H]norepinephrine, but not [3H]acetylcholine, from rat cerebral cortex.

Authors:  C W Bazil; K P Minneman
Journal:  J Neurochem       Date:  1989-09       Impact factor: 5.372

10.  Attenuation of endothelium-mediated vasodilation by halothane.

Authors:  S M Muldoon; J L Hart; K A Bowen; W Freas
Journal:  Anesthesiology       Date:  1988-01       Impact factor: 7.892

View more
  5 in total

1.  Antinociceptive effects of sinomenine in a rat model of postoperative pain.

Authors:  Qing Zhu; Yuehua Sun; Lina Mao; Chengpeng Liu; Bo Jiang; Wei Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2016-03-31       Impact factor: 8.739

2.  Niclosamide is a Negative Allosteric Modulator of Group I Metabotropic Glutamate Receptors: Implications for Neuropathic Pain.

Authors:  Ni Ai; Richard D Wood; Eric Yang; William J Welsh
Journal:  Pharm Res       Date:  2016-09-08       Impact factor: 4.200

3.  Inhibitory actions of diphenyleneiodonium on endothelium-dependent vasodilatations in vitro and in vivo.

Authors:  Y X Wang; C I Poon; K S Poon; C C Pang
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

4.  Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG-nitro-L-arginine and diphenyleneiodonium.

Authors:  Y X Wang; X Cheng; C C Pang
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Different pressor and bronchoconstrictor properties of human big-endothelin-1, 2 (1-38) and 3 in ketamine/xylazine-anaesthetized guinea-pigs.

Authors:  J P Gratton; G A Rae; A Claing; S Télémaque; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.